Study for the detection and prediction of skin irritation response of Xiaotong Tiegao

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027293

Enrollment

Unknown

Registered

2019-11-08

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritant contact dermatitis

Interventions

Case series:Xiaotong Tiegao

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years old; 2. Patients with acute or chronic contusion, or bruising pain, or bone hyperplasia, or rheumatism and rheumatoid pain, or stiff neck, or periarthritis of shoulder, or with lumbar muscle strain and old pain; 3. There is no pigmentation, damage or inflammation on the skin of the back.

Exclusion criteria

Exclusion criteria: 1. allergy to known experimental drugs; 2. serious liver and kidney diseases, diseases of the blood system, autoimmune diseases, mental disorders; 3. malignant tumors or other serious diseases that may affect the correct evaluation of efficacy; 4. local corticosteroid withdrawal time less than 2 weeks;Systemic use of corticosteroids and other immunosuppressive drugs (tripterygium wilfordii, etc.) withdrawal time less than 4 weeks; 5. other reasons considered unsuitable by researchers.

Design outcomes

Primary

Measure	Time frame
Sebum composition detection;	—

Countries

China

Contacts

Public ContactLin-feng Li

Beijing Friendship Hospital, Capital Medical University

zoonli@sina.com+86 13693620186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026